Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine

BACKGROUND: Development of a core outcome set (COS) for clinical trials for COVID-19 is urgent because of the pandemic wreaking havoc worldwide and the heterogeneity of outcomes in clinical trials. METHODS: A preliminary list of outcomes was developed after a systematic review of protocols of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Ruijin, Zhao, Chen, Liang, Tengxiao, Hao, Xuezeng, Huang, Ya, Zhang, Xiaoyu, Chen, Zhao, Wei, Xuxu, Zhao, Mengzhu, Zhong, Changming, Hu, Jiayuan, Li, Min, Han, Songjie, He, Tianmai, Sun, Yang, Chen, Jing, Shang, Hongcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265660/
https://www.ncbi.nlm.nih.gov/pubmed/32574235
http://dx.doi.org/10.3389/fphar.2020.00781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265660/
https://www.ncbi.nlm.nih.gov/pubmed/32574235
http://dx.doi.org/10.3389/fphar.2020.00781

Ejemplares similares